A Mammography FastTrack Program in Increasing the Number of Women Undergoing Breast Cancer Screening
|ClinicalTrials.gov Identifier: NCT00462891|
Recruitment Status : Completed
First Posted : April 19, 2007
Last Update Posted : May 21, 2013
RATIONALE: Screening may help doctors find breast cancer cells early and plan better treatment for breast cancer. The Mammography FastTrack program may be effective in increasing the number of patients who undergo mammography.
PURPOSE: This randomized clinical trial is studying the use of a Mammography FastTrack program to increase the number of women who undergo mammography.
|Condition or disease||Intervention/treatment|
|Breast Cancer||Other: IT System|
- Classify all patients within the Massachusetts General Primary Care-Practice Based Research Network (MGPC-PBRN) according to patient-primary care provider (PCP) linkage status.
- Develop a breast cancer screening intervention program called Mammography FastTrack that facilitates the ordering of mammograms to be used either by PCPs (for PCP-linked patients) or by practice managers (for practice-linked patients).
- Compare the impact of the Mammography FastTrack program on mammography screening rates in PCP-linked vs practice-linked patients overdue for breast cancer screening.
OUTLINE: This is a randomized, multicenter study.
Mammography-eligible women are linked to either a provider or a practice within the Massachusetts General Primary Care Practice-Based Research Network (MGPC-PBRN). Practices within the MGPC-PBRN are stratified according to baseline mammography screening rates (high vs low) and practice type (community health center vs hospital-based vs community-based) and are randomized to 1 of 2 arms.
- Arm I: Physicians and practice managers receive e-mail alerts at months 1 and 3 informing them of the availability of mammography screening data for their panel of primary-care patients. A hyperlink refers the provider to a web-portal for the Mammography FastTrack program that lists all eligible patients who have not undergone mammography. The provider may then click a button to schedule, defer (providing reason for deferral), or provide the date of a recent mammogram.
- Arm II: Practices continue standard care. At the end of 12 months, electronic report and billing data and a review of electronic health records are used to determine the completion of mammograms.
PROJECTED ACCRUAL: A total of 6,730 patients will be accrued for this study.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||6730 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||Breast Cancer Screening and Follow-Up in a PBRN: The Mammography FastTrack Trial|
|Study Start Date :||March 2007|
|Primary Completion Date :||March 2008|
Experimental: IT System
IT system to send reminder letters to patients overdue for breast cancer screening.
|Other: IT System|
|No Intervention: Usual Care|
- Proportion of overdue patients completing mammography screening in intervention and control groups [ Time Frame: 1 year ]Proportion of overdue patients completing mammography screening in intervention and control groups over the 1-year study.
- Difference in percentage of patients overdue at baseline receiving mammogram during the study period in intervention and control practices at 6 months [ Time Frame: 1 year ]
- Comparison of time to mammography completion in intervention vs control groups [ Time Frame: 1 year ]
- Clinical and nonclinical outcomes recorded by Mammography FastTrack tool [ Time Frame: 1 year ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00462891
|United States, Massachusetts|
|Massachusetts General Hospital|
|Boston, Massachusetts, United States, 02114|
|Study Chair:||Michael J. Barry, MD||Massachusetts General Hospital|